2013 was a year of successes for AB Vista, consolidating its position as one of the leading top three global feed enzyme suppliers. 2013 saw AB Vista open new offices in the U.S., Singapore and Brazil, along with supporting the investment in the new enzyme production facility at Evansville, Ind., in cooperation with sister company PGP international.
Much of AB Vista's growth has been driven by the success of enhanced phytase Quantum Blue. Through leading the debate on the importance of phytate degradation, AB Vista has helped to shift industry thinking, making the practice of superdosing for low phytate nutrition more commonplace, thus increasing the financial return for feed producers globally.
With focused investment on research and development, AB Vista continues to develop ground-breaking products and unique services to set new standards for the industry.
During the 2014 IPPE, attendees can visit the AB Vista stand to find out more about how the company plans to continue to bring new ways of thinking to the market in 2014. One particular area of focus for AB Vista in 2014, will be the Inspire Forum which aims to create an open platform for discussion around fibre-degrading feed enzymes and their substrates, due to take place in the spring.
"One of the most exciting aspects of AB Vista as a company is just how far it has come in such a short time, only having been formed in 2004 with just five staff (members) and a single office in the UK. We now span the globe, with over 120 staff," said Dieter Suida, AB Vista's regional director for the Americas.
"As a company, we're committed to innovation, both in developing better products, and in driving improvements in the supply chain and support services, with the aim of continuing to improve customer experience year-on-year," Suida continued. "With continued product and services development, I can confidently say there is much more to come from AB Vista."